Novel Spiro[Indene-1,2′-Quinazolin]-4′(3′H)-One Derivatives As Potent Anticonvulsant Agents: One-Pot Synthesis, in Vivo Biological Evaluation, and Molecular Docking Studies

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Novel Spiro[Indene-1,2′-Quinazolin]-4′(3′H)-One Derivatives As Potent Anticonvulsant Agents: One-Pot Synthesis, in Vivo Biological Evaluation, and Molecular Docking Studies Publisher Pubmed

Mohammadi AA¹ ; Taheri S¹ ; Shisheboran S¹ ; Ahdenov R¹ ; Mohammadikhanaposhtani M² ; Darjani PS³ ; Masihi PH⁴ ; Shakiba A⁴ ; Larijani B⁵ ; Mahdavi M⁵ ; Ahangar N^{6, 7}

Source: Journal of Biochemical and Molecular Toxicology Published:2023

Abstract

A new series of spiro[indene-1,2′-quinazolin]-4′(3′H)-one derivatives 4a–m were synthesized via a one-pot method and evaluated for anticonvulsant activities using pentylenetetrazole (PTZ) and maximal electroshock (MES)-induced seizures. Obtained results demonstrated that these compounds have not anticonvulsant activity in PTZ test while are active in the MES test. Among the synthesized compounds, the best anticonvulsant activity was obtained with compound 4h. This compound also was not neurotoxic. Given that the title new compounds have the pharmacophore requirement for benzodiazepine (BZD) receptor agonist, the most potent compound was assayed in vivo and in silico as BZD receptor agonist. After treatment with flumazenil as a standard BZD receptor antagonist, anticonvulsant activity of compound 4h decreased. Therefore, the involvement of BZD receptors in anticonvulsant activity of this compound confirmed. Furthermore, docking study of compound 4h in the BZD-binding site of GABAA receptor confirmed that this compound interacted with the important residues. © 2022 Wiley Periodicals LLC.

Related Docs

View other Related Docs

1. Design, Synthesis, Pharmacological Evaluation, and Docking Study of New Acridone-Based 1,2,4-Oxadiazoles As Potential Anticonvulsant Agents, European Journal of Medicinal Chemistry (2016)

2. Novel Fused 1,2,3-Triazolo-Benzodiazepine Derivatives As Potent Anticonvulsant Agents: Design, Synthesis, in Vivo, and in Silico Evaluations, Molecular Diversity (2020)

3. Anticonvulsant Activity of 1,2,4-Triazine Derivatives With Pyridyl Side Chain: Synthesis, Biological, and Computational Study, Medicinal Chemistry Research (2015)

Experts (# of related papers)

View all Related Experts

Ahmad Reza Dehpour (6)

Mohsen Amini (4)

Other Related Docs

4. Anticonvulsant Effects of Aerial Parts of Verbena Officinalis Extract in Mice: Involvement of Benzodiazepine and Opioid Receptors, Journal of Evidence-Based Complementary and Alternative Medicine (2017)

5. Isatoic Anhydride: A Fascinating and Basic Molecule for the Synthesis of Substituted Quinazolinones and Benzo Di/Triazepines, Current Organic Chemistry (2019)

6. Evaluation of Anxiolytic, Sedative-Hypnotic and Amnesic Effects of Novel 2-Phenoxy Phenyl-1,3,4-Oxadizole Derivatives Using Experimental Models, Iranian Journal of Pharmaceutical Research (2015)

7. The Importance of Triazole Scaffold in the Development of Anticonvulsant Agents, European Journal of Medicinal Chemistry (2016)

8. Benzylidene Barbituric Acid Derivatives Shown Anticonvulsant Activity on Pentylenetetrazole-Induced Seizures in Mice: Involvement of Nitric Oxide Pathway, Pharmaceutical Sciences (2018)

9. Hybridization of the Effective Pharmacophores for Treatment of Epilepsy: Design, Synthesis, in Vivo Anticonvulsant Activity, and in Silico Studies of Phenoxyphenyl-1,3,4-Oxadiazole-Thio-N-Phenylacetamid Hybrids, BMC Chemistry (2023)

10. Novel 4-Thiazolidinone Derivatives As Agonists of Benzodiazepine Receptors: Design, Synthesis and Pharmacological Evaluation, EXCLI Journal (2017)

11. Synthesis, in Vivo and in Silico Studies of N-Aryl-4-(1,3-Dioxoisoindolin-2-Yl)Benzamides As an Anticonvulsant Agent, Pharmaceutical Sciences (2020)

12. Design, Synthesis, Anticonvulsant Evaluation, and Molecular Docking Studies of New Gabaa Agonist Derivatives, Iranian Journal of Pharmaceutical Research (2025)

13. 2, 5-Disubstituted Phthalimides: Design, Synthesis and Anticonvulsant Activity in Scptz and Mes Models, Current Computer-Aided Drug Design (2018)

14. Novel Derivatives of Phthalimide With Potent Anticonvulsant Activity in Ptz and Mes Seizure Models, Iranian Journal of Basic Medical Sciences (2017)

15. 5-[Aryloxypyridyl (Or Nitrophenyl)]-4H-1,2,4-Triazoles As Novel Flexible Benzodiazepine Analogues: Synthesis, Receptor Binding Affinity and Lipophilicity-Dependent Anti-Seizure Onset of Action, Bioorganic Chemistry (2021)

16. Design, Synthesis, in Vivo, and in Silico Evaluation of New Coumarin-1,2,4-Oxadiazole Hybrids As Anticonvulsant Agents, Bioorganic Chemistry (2019)

17. Anticonvulsant Effects of Lippia Citriodora (Verbenaceae) Leaves Ethanolic Extract in Mice: Role of Gabaergic System, International Journal of Preventive Medicine (2016)

18. Psilocin, a Psychedelic Drug, Exerts Anticonvulsant Effects Against Ptz- and Mes-Induced Seizures in Mice Via 5-Ht1a and Cb1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways, Pharmacology Research and Perspectives (2025)

19. Possible Interaction of Opioidergic and Nitrergic Pathways in the Anticonvulsant Effect of Ivermectin on Pentylenetetrazole-Induced Clonic Seizures in Mice, Neurochemical Research (2023)

20. Anticonvulsant Effects of New 1, 4-Dihydropyridinederivatives Containing Imidazolyl Moiety Against Seizures Induced by Pentylenetetrazole and Maximal Electroshock in Mice, Iranian Journal of Pharmaceutical Research (2017)

Style	Citing Format
MLA	Mohammadi AA, et al.. "Novel Spiro[Indene-1,2′-Quinazolin]-4′(3′H)-One Derivatives As Potent Anticonvulsant Agents: One-Pot Synthesis, in Vivo Biological Evaluation, and Molecular Docking Studies." Journal of Biochemical and Molecular Toxicology, vol. 37, no. 1, 2023, pp. -.
APA	Mohammadi AA, Taheri S, Shisheboran S, Ahdenov R, Mohammadikhanaposhtani M, Darjani PS, Masihi PH, Shakiba A, Larijani B, Mahdavi M, Ahangar N (2023). Novel Spiro[Indene-1,2′-Quinazolin]-4′(3′H)-One Derivatives As Potent Anticonvulsant Agents: One-Pot Synthesis, in Vivo Biological Evaluation, and Molecular Docking Studies. Journal of Biochemical and Molecular Toxicology, 37(1), -.
Chicago	Mohammadi AA, Taheri S, Shisheboran S, Ahdenov R, Mohammadikhanaposhtani M, Darjani PS, Masihi PH, et al.. "Novel Spiro[Indene-1,2′-Quinazolin]-4′(3′H)-One Derivatives As Potent Anticonvulsant Agents: One-Pot Synthesis, in Vivo Biological Evaluation, and Molecular Docking Studies." Journal of Biochemical and Molecular Toxicology 37, no. 1 (2023): -.
Harvard	Mohammadi AA et al. (2023) 'Novel Spiro[Indene-1,2′-Quinazolin]-4′(3′H)-One Derivatives As Potent Anticonvulsant Agents: One-Pot Synthesis, in Vivo Biological Evaluation, and Molecular Docking Studies', Journal of Biochemical and Molecular Toxicology, 37(1), pp. -.
Vancouver	Mohammadi AA, Taheri S, Shisheboran S, Ahdenov R, Mohammadikhanaposhtani M, Darjani PS, et al.. Novel Spiro[Indene-1,2′-Quinazolin]-4′(3′H)-One Derivatives As Potent Anticonvulsant Agents: One-Pot Synthesis, in Vivo Biological Evaluation, and Molecular Docking Studies. Journal of Biochemical and Molecular Toxicology. 2023;37(1):-.
BibTex	@article{ author = {Mohammadi AA and Taheri S and Shisheboran S and Ahdenov R and Mohammadikhanaposhtani M and Darjani PS and Masihi PH and Shakiba A and Larijani B and Mahdavi M and Ahangar N}, title = {Novel Spiro[Indene-1,2′-Quinazolin]-4′(3′H)-One Derivatives As Potent Anticonvulsant Agents: One-Pot Synthesis, in Vivo Biological Evaluation, and Molecular Docking Studies}, journal = {Journal of Biochemical and Molecular Toxicology}, volume = {37}, number = {1}, pages = {-}, year = {2023} }
RIS	TY - JOUR AU - Mohammadi AA AU - Taheri S AU - Shisheboran S AU - Ahdenov R AU - Mohammadikhanaposhtani M AU - Darjani PS AU - Masihi PH AU - Shakiba A AU - Larijani B AU - Mahdavi M AU - Ahangar N TI - Novel Spiro[Indene-1,2′-Quinazolin]-4′(3′H)-One Derivatives As Potent Anticonvulsant Agents: One-Pot Synthesis, in Vivo Biological Evaluation, and Molecular Docking Studies JO - Journal of Biochemical and Molecular Toxicology VL - 37 IS - 1 SP - EP - PY - 2023 ER -

Science Communicator Platform

Authors

Abstract